Get started
Insmed IncorporatedInsmed IncorporatedInsmed Incorporated

Insmed Incorporated

No trades
See on Supercharts
Overview
Financials News Ideas Discussions Technicals Forecast Seasonals Options Bonds

INSM chart


Full chart

INSM upcoming earnings


Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪14.06 B‬ USD
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−5.59 USD
Net income (FY)
‪−913.77 M‬ USD
Revenue (FY)
‪363.71 M‬ USD
Shares float
‪176.82 M‬
Beta (1Y)
1.28

Employees


Employees (FY)
‪1.27 K‬
Change (1Y)
+359 +39.36%
Revenue / Employee (1Y)
‪286.16 K‬ USD
Net income / Employee (1Y)
‪−718.94 K‬ USD

About Insmed Incorporated


Sector
Health Technology
Industry
Pharmaceuticals: Major
CEO
William H. Lewis
Website
insmed.com
Headquarters
Bridgewater
Founded
1988
FIGI
BBG000BWM5P3
Insmed, Inc. is a global biopharmaceutical company, which engages in the development and commercialization of therapies for patients with rare diseases. Its focuses on Brensocatib, and Treprostinil Palmitil Inhalation Powder (TPIP) pipeline. The company was founded in 1988 and is headquartered in Bridgewater, NJ.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

INSM news



Ideas



See all ideas 

Technicals


Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

INSM highest yielding bonds


INSM5182680
Insmed Incorporated 0.75% 01-JUN-2028
Yield to maturity
−18.09%
Maturity date
Jun 1, 2028

See all INSM bonds 


Check out other big names from the same industry as INSM.

Frequently Asked Questions


The current price of INSM is 77.15 USD — it has decreased by −0.91% in the past 24 hours. Watch Insmed Incorporated stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Insmed Incorporated stocks are traded under the ticker INSM.
INSM stock has fallen by −1.99% compared to the previous week, the month change is a −2.15% fall, over the last year Insmed Incorporated has showed a 183.44% increase.
We've gathered analysts' opinions on Insmed Incorporated future price: according to them, INSM price has a max estimate of 110.00 USD and a min estimate of 89.00 USD. Watch INSM chart and read a more detailed Insmed Incorporated stock forecast: see what analysts think of Insmed Incorporated and suggest that you do with its stocks.
INSM reached its all-time high on Aug 30, 2000 with the price of 199.38 USD, and its all-time low was 2.64 USD and was reached on Nov 25, 2011. View more price dynamics on INSM chart.
See other stocks reaching their highest and lowest prices.
INSM stock is 2.31% volatile and has beta coefficient of 1.28. Track Insmed Incorporated stock price on the chart and check out the list of the most volatile stocks — is Insmed Incorporated there?
Today Insmed Incorporated has the market capitalization of ‪14.06 B‬, it has increased by 5.52% over the last week.
Yes, you can track Insmed Incorporated financials in yearly and quarterly reports right on TradingView.
Insmed Incorporated is going to release the next earnings report on May 1, 2025. Keep track of upcoming events with our Earnings Calendar.
INSM earnings for the last quarter are −1.32 USD per share, whereas the estimation was −1.17 USD resulting in a −12.74% surprise. The estimated earnings for the next quarter are −1.35 USD per share. See more details about Insmed Incorporated earnings.
Insmed Incorporated revenue for the last quarter amounts to ‪104.44 M‬ USD, despite the estimated figure of ‪102.08 M‬ USD. In the next quarter, revenue is expected to reach ‪91.65 M‬ USD.
INSM net income for the last quarter is ‪−235.55 M‬ USD, while the quarter before that showed ‪−220.52 M‬ USD of net income which accounts for −6.81% change. Track more Insmed Incorporated financial stats to get the full picture.
No, INSM doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Mar 28, 2025, the company has ‪1.27 K‬ employees. See our rating of the largest employees — is Insmed Incorporated on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Insmed Incorporated EBITDA is ‪−775.56 M‬ USD, and current EBITDA margin is −213.24%. See more stats in Insmed Incorporated financial statements.
Like other stocks, INSM shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Insmed Incorporated stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Insmed Incorporated technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Insmed Incorporated stock shows the buy signal. See more of Insmed Incorporated technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.